81 related articles for article (PubMed ID: 5558022)
1. [Safety of tolbutamid treatment in diabetic patients].
Cohen AM
Harefuah; 1971 Jan; 80(1):33. PubMed ID: 5558022
[No Abstract] [Full Text] [Related]
2. [Severe hypoglycemia due to Dirastan (tolbutamide) in a diabetic with chronic renal failure].
Bures J; Fixa B; Kaut V; Herout V; Hrncír Z
Vnitr Lek; 1982 Jul; 28(7):678-84. PubMed ID: 7112992
[No Abstract] [Full Text] [Related]
3. Oral diabetic drugs again held hazardous.
J Tenn Med Assoc; 1975 Apr; 68(4):343. PubMed ID: 1117724
[No Abstract] [Full Text] [Related]
4. A note on tolbutamide and diabetes.
Med Lett Drugs Ther; 1970 Jul; 12(14):60. PubMed ID: 4935987
[No Abstract] [Full Text] [Related]
5. Tolbutamide (Orinase) and diabetes.
Med Lett Drugs Ther; 1970 Nov; 12(24):97-8. PubMed ID: 5514167
[No Abstract] [Full Text] [Related]
6. The tolbutamide controversy.
Compr Ther; 1975 May; 1(1):19-20. PubMed ID: 1222531
[No Abstract] [Full Text] [Related]
7. Medical guest editorial: The oral diabetic drug controversy.
Am Fam Physician; 1975 Dec; 12(6):73-4. PubMed ID: 1202930
[No Abstract] [Full Text] [Related]
8. Tolbutamide and diabetes.
Can Med Assoc J; 1971 Jun; 104(12):1067. PubMed ID: 5580750
[No Abstract] [Full Text] [Related]
9. Tolbutamide photosensitivity.
Kar PK; Das Gupta SK; Das KD
J Indian Med Assoc; 1984 Aug; 82(8):289-91. PubMed ID: 6491339
[No Abstract] [Full Text] [Related]
10. Tolbutamide: another view.
Nahum LH
Conn Med; 1971 Apr; 35(4):272-3. PubMed ID: 5108037
[No Abstract] [Full Text] [Related]
11. Anti-diabetic drugs as a cause of hypoglycaemia among acute medical admissions in Hong Kong and Singapore--relationship to the prescribing patterns in diabetic patients.
Chan TY
Singapore Med J; 1998 Apr; 39(4):186-8. PubMed ID: 9676153
[TBL] [Abstract][Full Text] [Related]
12. [Monocytic leukemia during long-term tolbutamide therapy].
Schneider H; Slowik R; Wache HW
Z Gesamte Inn Med; 1970 Jan; 25(2):88-90. PubMed ID: 5268133
[No Abstract] [Full Text] [Related]
13. Controlled clinical trials and the tolbutamide controversy.
Lavietes PH
Conn Med; 1971 Apr; 35(4):271-2. PubMed ID: 4927818
[No Abstract] [Full Text] [Related]
14. Controversy in diabetes mellitus.
Jackson WP
S Afr Med J; 1979 Jun; 55(27):1104. PubMed ID: 483092
[No Abstract] [Full Text] [Related]
15. [Attack after oral antidiabetics].
Frey H
Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2097-8. PubMed ID: 5479224
[No Abstract] [Full Text] [Related]
16. Hypoglycemic coma in a diabetic patient treated with tolbutamide.
Kindschi LG
Wis Med J; 1966 Mar; 65(3):120-1. PubMed ID: 5907293
[No Abstract] [Full Text] [Related]
17. [Increased hazards of tablet therapy in diabetes].
Dtsch Med Wochenschr; 1970 Jul; 95(29):1544. PubMed ID: 5427548
[No Abstract] [Full Text] [Related]
18. The tolbutamide controversy.
JAMA; 1970 Aug; 213(5):861. PubMed ID: 5468633
[No Abstract] [Full Text] [Related]
19. [Immediate effect of short-lasting insulin administration on the action of tolbutamide in diabetic patients].
Grabowska MJ
Pol Tyg Lek; 1967 Jul; 22(28):1064-6. PubMed ID: 6061141
[No Abstract] [Full Text] [Related]
20. [Hypoglycemic coma caused by D860].
Fujita S; Tsuneda T; Kondo K; Suzuki K
Naika; 1967 Jan; 19(1):179-82. PubMed ID: 6060638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
